Przejdź do zawartości
Merck

A protocol for constructing gene targeting vectors: generating knockout mice for the cadherin family and beyond.

Nature protocols (2008-06-13)
Sen Wu, Guoxin Ying, Qiang Wu, Mario R Capecchi
ABSTRAKT

We describe here a streamlined procedure for targeting vector construction, which often is a limiting factor for gene targeting (knockout) technology. This procedure combines various highly efficient recombination-based cloning methods in bacteria, consisting of three steps. First step is the use of Red-pathway-mediated recombination (recombineering) to capture a genomic fragment into a Gateway-compatible vector. Second, the vector is modified by recombineering to include a positive selection gene neo, from a variety of modular reagents. Finally, through a simple in vitro Gateway recombination, the modified genomic fragment is switched into a vector that contains negative selection cassettes, as well as unique sites for linearization. To demonstrate the usefulness of this protocol, we report targeted disruptions of members of the cadherin gene family, focusing on those that have not been previously studied at the molecular genetic level. This protocol needs 2 weeks to construct a targeting vector, and several vectors can be easily handled simultaneously using common laboratory setup.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Sigma-Aldrich
Bovine Serum Albumin, heat shock fraction, pH 5.2, ≥96%
Roche
Tris hydrochloride, >99% (titration), pH 7.0-9.0, suitable for FISH
Sigma-Aldrich
Spermidine trihydrochloride, ≥98% (TLC)
Sigma-Aldrich
ESGRO® Recombinant Mouse LIF Protein, ESGRO Leukemia Inhibitory Factor (LIF) supplement for mouse ES cell culture. Each vial contains 10^7 units/ml.